Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
13/05/2025 21:27
May 13 (Reuters) - TherapeuticsMD Inc TXMD.O: THERAPEUTICSMD Q1 OPERATING EXPENSES USD 1.264 MILLION THERAPEUTICSMD Q1 NET INCOME FROM CONTINUING OPERATIONS USD -636 THOUSAND Source text: ID:nBw4RFqZ8a Further company coverage: TXMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract